NCT02509507 Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 Status COMPLETED Phase PHASE1/PHASE2
NCT02504983 Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma Status UNKNOWN Phase PHASE4
NCT02487017 DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT02472249 Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC Status COMPLETED Phase PHASE4
NCT02471313 Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization Status COMPLETED Phase PHASE2
NCT02460991 A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma Status TERMINATED Phase PHASE3
NCT02460835 A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma Status COMPLETED Phase NA
NCT02446925 Surefire Catheter Versus Standard End-hole Microcatheter: A Pilot Study Status TERMINATED Phase NA
NCT02436044 HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC Status APPROVED_FOR_MARKETING Phase N/A
NCT02435953 TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT02435433 A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein Status COMPLETED Phase PHASE3
NCT02432963 Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02426450 RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC Status UNKNOWN Phase PHASE2
NCT02425605 Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT02424955 Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation Status COMPLETED Phase NA
NCT02423239 A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours Status UNKNOWN Phase PHASE1